Claud Grigg
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 8
- Lung Cancer Research Studies 4
- Peptidase Inhibition and Analysis 3
-
- Lung Cancer Treatments and Mutations 4
- Renal cell carcinoma treatment 3
- Co-authors
- Naiyer A. Rizvi (5 shared papers)Robert Samstein (1 shared paper)Vladimir Makarov (1 shared paper)David B. Solit (1 shared paper)David Requena (1 shared paper)Edward B. Garon (1 shared paper)Jeffrey K. Weber (1 shared paper)Diego Chowell (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Urologic Oncology Seminars and Original Investigations (4 papers)The Journal of Urology (2 papers)Science (1 paper)Seminars in Oncology (1 paper)
- Partner nations
- United States
In The Last Decade
Claud Grigg
19 papers receiving 1.5k citations
Claud Grigg's Hit Papers
Peers
Comparison fields: 5 of 66
- Oncology 1.2k
- Immunology 490
- Pulmonary and Respiratory Medicine 681
- Cancer Research 212
- Radiology, Nuclear Medicine and Imaging 106
Countries citing papers authored by Claud Grigg
This map shows the geographic impact of Claud Grigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claud Grigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claud Grigg more than expected).
Fields of papers citing papers by Claud Grigg
This network shows the impact of papers produced by Claud Grigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claud Grigg. The network helps show where Claud Grigg may publish in the future.
Co-authors
The 25 scholars most cited alongside Claud Grigg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy Hit paper breakdown → | 2017 | 738 |
| 2 | Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial Hit paper breakdown → | 2020 | 425 |
| 3 | 2016 | 160 | |
| 4 | 2016 | 51 | |
| 5 | 2017 | 32 | |
| 6 | 2018 | 31 | |
| 7 | 2019 | 27 | |
| 8 | 2020 | 14 | |
| 9 | 2021 | 10 | |
| 10 | 2019 | 5 | |
| 11 | 2021 | 4 | |
| 12 | 2023 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2020 | 2 | |
| 15 | 2019 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2022 | 1 | |
| 20 | 2020 | 0 |
About Claud Grigg
Claud Grigg is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Epidemiology, having authored 22 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Bladder and Urothelial Cancer Treatments (7 papers), Urinary and Genital Oncology Studies (6 papers), Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers), Peptidase Inhibition and Analysis (3 papers), Renal cell carcinoma treatment (3 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (490 citations), Pulmonary and Respiratory Medicine (681 citations), Cancer Research (212 citations) and Radiology, Nuclear Medicine and Imaging (106 citations). Claud Grigg has collaborated with scholars based in United States. Frequent co-authors include Naiyer A. Rizvi, Robert Samstein, Vladimir Makarov, David B. Solit, David Requena, Edward B. Garon, Jeffrey K. Weber, Diego Chowell, Sviatoslav M. Kendall and Ahmet Zehir. Their work appears in journals such as Journal of Clinical Oncology, Urologic Oncology Seminars and Original Investigations, The Journal of Urology, Science and Seminars in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.